BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia

Published:2013-07 Issue:7 Volume:3 Page:e126-e126
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer Journal

Author:

Da Costa D,Agathanggelou A,Perry T,Weston V,Petermann E,Zlatanou A,Oldreive C,Wei W,Stewart G,Longman J,Smith E,Kearns P,Knapp S,Stankovic T

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://www.nature.com/articles/bcj201324.pdf

Reference45 articles.

1. Campana D . Molecular determinants of treatment response in acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program 2008; 2008: 366–373.

2. Campana D . Minimal residual disease in acute lymphoblastic leukemia. Semin Hematol 2009; 46: 100–106.

3. Mitchell C, Payne J, Wade R, Vora A, Kinsey S, Richards S et al. The impact of risk stratification by early bone-marrow response in childhood lymphoblastic leukaemia: results from the United Kingdom Medical Research Council trial ALL97 and ALL97/99. Br J Haematol 2009; 146: 424–436.

4. Bhatia S . Late effects among survivors of leukemia during childhood and adolescence. Blood Cells Mol Dis 2003; 31: 84–92.

5. Kaste SC, Jones-Wallace D, Rose SR, Boyett JM, Lustig RH, Rivera GK . Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: frequency of occurrence and risk factors for their development. Leukemia 2001; 15: 728–734.

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Successes and challenges in the development of BD1-selective BET inhibitors: a patent review;Expert Opinion on Therapeutic Patents;2024-03-11

2. In the Pipeline—Emerging Therapy for ALL;Pathogenesis and Treatment of Leukemia;2023

3. Unusual B-Lymphoid Blastic Crisis as Initial Presentation of Chronic Myeloid Leukemia Imposes Diagnostic Challenges;Case Reports in Hematology;2022-06-25

4. Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia;Frontiers in Oncology;2021-12-01

5. Synthesis, molecular structure, DFT studies, in silico docking and molecular dynamics simulations of 2,6 dimethoxychalcone derivatives as BRD4 inhibitors;Journal of Molecular Structure;2021-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3